Home

Continuous

Non-Invasive

Drug Delivery

Home Slide 1

Continuous

Non-Invasive

Drug Delivery

Leo Lens Pharma

Selected as a

2020 Cool Company

Cool Companies

Leo Lens Pharma

Selected as a

2020 Cool Company

Learn about the

MediPrint™ Process

Video

Learn about the

MediPrint™ Process

Leo Lens Pharma

Selected as a

OTS 2020 Presenting Company

OTS 2020

Leo Lens Pharma

Selected as a

OTS 2020 Presenting Company


Harnesses The Power Of Digital Printing

Leo Lens successfully harnesses the power of digital printing, with its patented MediPrint™ process, to use contact lenses as a continuous drug delivery systems. Applying our cutting-edge patented technology and leveraging digital printing methods, we create enhanced contact lenses that help treat eye disease. Contact us today to learn more about using our broad and versatile technology platform for your next generation products.
Learn More

Explore Our MediPrint™ Products

Medicated Lenses

Medicated Lenses

Harnessing the power of the MediPrint™ process to print drug layers on FDA-approved contact lenses, Leo Lens uses its proprietary technology to develop contact lenses that provide sustained drug delivery of medications for ocular disease. This novel approach to treating glaucoma, dry eye, allergies, and other eye diseases is cost-effective and integrates seamlessly with existing manufacturing processes.

Learn More

“We want to leave a footprint, creating a world in which all preventable blindness is eliminated.” ~ Praful Doshi, Founder

Applications
Community
Company
Associations
Biocom Member

© 2018 Leo Lens Technology, Inc.